Hot Pursuit     13-Jun-24
J B Chemicals & Pharmaceuticals Ltd up for fifth session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 1900, up 0.35% on the day as on 12:44 IST on the NSE. The stock is up 74.54% in last one year as compared to a 24.72% gain in NIFTY and a 52.65% gain in the Nifty Pharma.

J B Chemicals & Pharmaceuticals Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1900, up 0.35% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.3% on the day, quoting at 23393.15. The Sensex is at 76831.31, up 0.29%. J B Chemicals & Pharmaceuticals Ltd has added around 5.72% in last one month.

Meanwhile, Nifty Pharma index of which J B Chemicals & Pharmaceuticals Ltd is a constituent, has added around 5.03% in last one month and is currently quoting at 19739.1, up 0.35% on the day. The volume in the stock stood at 46862 shares today, compared to the daily average of 2.07 lakh shares in last one month.

The PE of the stock is 53.97 based on TTM earnings ending March 24.

Previous News
  Board of J B Chemicals & Pharmaceuticals recommends final dividend
 ( Corporate News - 18-May-24   09:31 )
  J B Chemicals & Pharmaceuticals consolidated net profit rises 43.97% in the March 2024 quarter
 ( Results - Announcements 18-May-24   09:31 )
  J B Chemicals & Pharmaceuticals grants 83,497 stock options
 ( Corporate News - 09-Aug-23   18:17 )
  J B Chemicals & Pharmaceuticals receives USFDA approval for Doxepin Hydrochloride capsules
 ( Corporate News - 23-Aug-23   14:09 )
  Volumes spurt at Kotak Mahindra Bank Ltd counter
 ( Hot Pursuit - 29-Feb-24   11:00 )
  JB Pharma jumps on USFDA nod for anxiety drug
 ( Hot Pursuit - 23-Aug-23   12:57 )
  J B Chemicals & Pharmaceuticals to convene board meeting
 ( Corporate News - 02-Aug-23   16:51 )
  J B Chemicals & Pharmaceuticals to discuss results
 ( Corporate News - 27-Jul-22   11:54 )
  Board of J B Chemicals & Pharmaceuticals approves setting up of step-down subsidiary in Philippines
 ( Corporate News - 09-Aug-23   18:16 )
  J B Chemical receives USFDA approval for Venlafaxine Extended Release Tablets
 ( Corporate News - 30-Nov-22   16:24 )
  Board of J B Chemicals & Pharmaceuticals recommends final dividend
 ( Corporate News - 27-May-23   17:59 )
Other Stories
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
  HDFC Bank Ltd spurts 2.62%, rises for third straight session
  03-Jul-24   13:05
Back Top